BioArctic AB (publ) (OM: BIOA B)
Health Care · Biotechnology · SE
Skr304.40
-0.13% today · +7.7% 1Y
Public summary
A free snapshot of BioArctic AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app BioArctic AB (publ) (OM: BIOA B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.65B.
Over the last twelve months the share price has gained 7.7%, trading between 275.80 and 364.40.
Tweenvest scores BioArctic AB (publ) across four factors: quality 65/100, value 12/100, growth 100/100, dividend 15/100. Its strongest factor is growth.
BIOA B price history
Key figures
- Market cap
- $2.65B
- Revenue (TTM)
- $103.43M
- P/E
- 257.02
- EPS
- 1.18
- Dividend yield
- 0.66%
- Beta (5Y)
- -0.63
- 52-week high
- Skr364.40
- 52-week low
- Skr275.80
- Avg volume (3M)
- —
- Shares outstanding
- 88.72M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xencor, Inc.NasdaqGM: XNCR | $2.78B | $37.09 | -2.73% |
| Zai Lab LimitedNasdaqGM: ZLAB | $2.77B | $24.60 | -5.53% |
| Celcuity Inc.NasdaqCM: CELC | $2.73B | $55.60 | -4.15% |
| Bavarian Nordic A/SCPSE: BAVA | $2.66B | Dkr243.00 | +0.83% |
| Keymed Biosciences Inc.SEHK: 2162 | $2.59B | HK$69.00 | -1.22% |
| Yili Chuanning Biotechnology Co.,Ltd.SZSE: 301301 | $2.54B | CN¥7.61 | -2.19% |
| Walvax Biotechnology Co., Ltd.SZSE: 300142 | $2.52B | CN¥10.51 | -2.41% |
| Xiamen Amoytop Biotech Co., Ltd.SHSE: 688278 | $2.51B | CN¥42.14 | -1.77% |